Are you over 18 and want to see adult content?
More Annotations
A complete backup of stuartwilsondesigns.com
Are you over 18 and want to see adult content?
A complete backup of larrybrownsports.com
Are you over 18 and want to see adult content?
A complete backup of mauiseasidehotel.com
Are you over 18 and want to see adult content?
A complete backup of ormiston-my.sharepoint.com
Are you over 18 and want to see adult content?
A complete backup of chikcz.tumblr.com
Are you over 18 and want to see adult content?
A complete backup of transparentkiwi.tumblr.com
Are you over 18 and want to see adult content?
Favourite Annotations
Best Down Comforter Reviews 2019
Are you over 18 and want to see adult content?
A complete backup of chicagoteacherstore.net
Are you over 18 and want to see adult content?
BANKING INDIA UPDATES – we facilitate banking literacy
Are you over 18 and want to see adult content?
myThiki.gr - Θήκες Κινητών-Αξεσουάρ για Smartphones και Tablets
Are you over 18 and want to see adult content?
Yeni İş Fikirleri | Girişimcilik | İş Kurmak | Bayilik Veren Firmalar
Are you over 18 and want to see adult content?
A complete backup of parkerwholesalecars.com
Are you over 18 and want to see adult content?
MD5 Online | Free and fast MD5 encryption
Are you over 18 and want to see adult content?
Text
PRACTICESERIES
Next Steps. May 27, 2021. Climate change is a devastating existential threat that can exaggerate preexisting inequities and health/mental health problems. As mental health professionals committed to understanding deep emotional wounds and addressing complexities of relationships, psychiatrists have the tools to assist in bridging thecurrent gaps.
CONFRONTING THE METHAMPHETAMINE EPIDEMIC Methamphetamine use has been underrecognized compared with the opioid use epidemic, but it is a major health care concern, due to rapidly increasing usage of this drug and its highly addictive pharmacologic properties. Methamphetamine use poses many psychological and physiological challenges to users. PSYCHIATRIC SYMPTOMS ASSOCIATED WITH PARKINSON DISEASE5 STAGES OFPARKINSON S DISEASE
Parkinson disease (PD) is the second most common neurodegenerative illness in the United States, affecting more than 1 million persons. Disease onset is usually after age 50. In persons older than 70 years, the prevalence is 1.5% to 2.5%.1 While the primary pathology involves degeneration of dopaminergic neurons in the substantia nigra, circuits important in emotion and cognition-such as the STRATEGIES FOR TREATMENT-RESISTANT OCD Strategies for Treatment-Resistant OCD. October 16, 2014. Stefano Pallanti, MD, PhD. Stefano Pallanti, MD, PhD. Psychiatric Times, Vol 31 No 10, Volume 31, Issue 10. The clinician's role is to “translate” symptoms of OCD and understand the dysfunctional circuits at play to decide on the most appropriate treatment for eachpatient. Figure.
PANDEMIC DENIERS: WHAT’S WITH THEM? Pandemic Deniers: What’s With Them? September 8, 2020. Lawrence H. Climo, MD. Lawrence H. Climo, MD. Some individuals refuse to wear masks or practice social distancing. Why? And what might change their minds? Pandemics occur worldwide. I don't think it is a reach to assume that each time they appear they evoke fear, the desire to stay NEW HOPE FOR DEPRESSION ON THE HORIZON The US Food and Drug Administration has reviewed and accepted the New Drug Application (NDA) for LY03005, a serotonin-norepinephrine-dopamine triple reuptake inhibitor (SNDRI). Developed under Luye Pharma's New Chemical and Therapeutic Entities Research and Development platform, the company has obtained patents covering the chemical compound HOW TO SWITCH STIMULANTS: A DOSING GUIDE FOR ADHD To convert to a new duration with the same formulation, multiply the old dose by the ratio of (new duration) / (old duration). This will increase the dose if the new duration is longer, and lower the dose if the new duration is shorter. The adjustment ensures that the new medication will deliver the same milligrams per hour, but it is only a HOW TO WORK THROUGH EROTIC TRANSFERENCE The therapeutic usefulness of the erotic transference is twofold: the wealth of psychological material it yields in understanding both erotic and power issues and the strength of the emotional charge that initially sustains the patient through some hard work. However, to the degree that it persists, it becomes a limitation in the analysis. HOW TO MINIMIZE LAMOTRIGINE’S ADVERSE EFFECTS BRIEF COMMUNICATION. Lamotrigine’s favorable tolerability is a welcome advance for patients with bipolar disorder, particularly in the areas that matter most to patients: weight gain, fatigue, sex, and cognition. 1 Unlike other mood stabilizers, lamotrigine lacks long-term medical risks. Rather, the danger it poses is at the start of treatment, when its mood-lifting effects can easily be LOW-DOSE LITHIUM: A DIFFERENT, IMPORTANT TOOL Low-dose lithium is a different drug compared with full-dose lithium (eg, blood level of 0.8 mEq/L and higher). It has a far more benign side-effect and risk profile. And it has different potential targets: not so much the prevention of the next manic episode but rather adjunctive antidepressant and anti-suicide effects. PSYCHIATRIC TIMESCMESPOTLIGHTCOMMENTARYCULTURAL CORNERPSYCHIATRICPRACTICESERIES
Next Steps. May 27, 2021. Climate change is a devastating existential threat that can exaggerate preexisting inequities and health/mental health problems. As mental health professionals committed to understanding deep emotional wounds and addressing complexities of relationships, psychiatrists have the tools to assist in bridging thecurrent gaps.
CONFRONTING THE METHAMPHETAMINE EPIDEMIC Methamphetamine use has been underrecognized compared with the opioid use epidemic, but it is a major health care concern, due to rapidly increasing usage of this drug and its highly addictive pharmacologic properties. Methamphetamine use poses many psychological and physiological challenges to users. PSYCHIATRIC SYMPTOMS ASSOCIATED WITH PARKINSON DISEASE5 STAGES OFPARKINSON S DISEASE
Parkinson disease (PD) is the second most common neurodegenerative illness in the United States, affecting more than 1 million persons. Disease onset is usually after age 50. In persons older than 70 years, the prevalence is 1.5% to 2.5%.1 While the primary pathology involves degeneration of dopaminergic neurons in the substantia nigra, circuits important in emotion and cognition-such as the PANDEMIC DENIERS: WHAT’S WITH THEM? Pandemic Deniers: What’s With Them? September 8, 2020. Lawrence H. Climo, MD. Lawrence H. Climo, MD. Some individuals refuse to wear masks or practice social distancing. Why? And what might change their minds? Pandemics occur worldwide. I don't think it is a reach to assume that each time they appear they evoke fear, the desire to stay STRATEGIES FOR TREATMENT-RESISTANT OCD Strategies for Treatment-Resistant OCD. October 16, 2014. Stefano Pallanti, MD, PhD. Stefano Pallanti, MD, PhD. Psychiatric Times, Vol 31 No 10, Volume 31, Issue 10. The clinician's role is to “translate” symptoms of OCD and understand the dysfunctional circuits at play to decide on the most appropriate treatment for eachpatient. Figure.
NEW HOPE FOR DEPRESSION ON THE HORIZON The US Food and Drug Administration has reviewed and accepted the New Drug Application (NDA) for LY03005, a serotonin-norepinephrine-dopamine triple reuptake inhibitor (SNDRI). Developed under Luye Pharma's New Chemical and Therapeutic Entities Research and Development platform, the company has obtained patents covering the chemical compound HOW TO SWITCH STIMULANTS: A DOSING GUIDE FOR ADHD To convert to a new duration with the same formulation, multiply the old dose by the ratio of (new duration) / (old duration). This will increase the dose if the new duration is longer, and lower the dose if the new duration is shorter. The adjustment ensures that the new medication will deliver the same milligrams per hour, but it is only a HOW TO WORK THROUGH EROTIC TRANSFERENCE The therapeutic usefulness of the erotic transference is twofold: the wealth of psychological material it yields in understanding both erotic and power issues and the strength of the emotional charge that initially sustains the patient through some hard work. However, to the degree that it persists, it becomes a limitation in the analysis. HOW TO MINIMIZE LAMOTRIGINE’S ADVERSE EFFECTS BRIEF COMMUNICATION. Lamotrigine’s favorable tolerability is a welcome advance for patients with bipolar disorder, particularly in the areas that matter most to patients: weight gain, fatigue, sex, and cognition. 1 Unlike other mood stabilizers, lamotrigine lacks long-term medical risks. Rather, the danger it poses is at the start of treatment, when its mood-lifting effects can easily be LOW-DOSE LITHIUM: A DIFFERENT, IMPORTANT TOOL Low-dose lithium is a different drug compared with full-dose lithium (eg, blood level of 0.8 mEq/L and higher). It has a far more benign side-effect and risk profile. And it has different potential targets: not so much the prevention of the next manic episode but rather adjunctive antidepressant and anti-suicide effects. EXPLORING THE EPIGENETIC PARADIGM SHIFT 3 hours ago · In the May 2021 issue of Nature Neuroscience, a research team at Icahn School of Medicine at Mount Sinai Health System in New York City made a fascinating discovery: Early life stress in mice resulted in an epigenetic modification of methyl groups on histone-3 in neurons in the nucleus accumbens, which in turn led to a lifelong increase in the mice’s vulnerability to stress.IN DEFENSE OF ECT
5 hours ago · Research data shows that ECT is often more effective than alternative treatments, and safe too. I would also like to thank Sarah Hancock, MS, CRC, Sue Cunliffe, MBchB, RCPCH, John Read, PhD for responding to my article “ECT: An Effective and Safe Treatment.” 1Their objections to
PARTNERING FOR THE GREATER GOOD 8 hours ago · A report published by the United States Department of Health and Human Services Health Resources and Services Administration projected that the mental health care field will be short 250,000 mental health professionals by 2025. 1 The need is most significant in rural areas, where 111 million Americans currently reside. 1 For instance in New Hampshire, where I live and practice, there are FINDING THE DIFFICULT TRUTH 1 day ago · A clinical approach to detecting false allegations of abuse in child custody cases. False allegations of abuse in child custody cases are an all-too-common phenomenon. Typically, one parent accuses the other parent of physical and/or sexual abuse of their child to gain leverage in their court RAISING DOUBTS ABOUT ECT 5 hours ago · Ms Hancock is a nationally certified rehabilitation counselor and former Clinical Rehabilitation Counseling and Clinical Mental Health faculty member at San Diego State University. Dr Cunliffe was a pediatrician until she left her job after undergoingECT.
NEW HOPE FOR PTSD TREATMENT? Dr Marques is a senior clinical fellow on the Faculty of Medicine at Imperial College London, an instructor at the Institute of Psychiatry in King’s College, and the CEO of Pasithea Therapeutics. The latest trial results for MDMA-assisted therapy are in—and they are eye-catching. Existing THE PANDEMIC PROJECT: OUR READERS DESCRIBE THE YEAR OF It seems all of us started with some degree of built-in evolutionary reaction to perceived danger, “fight or flight,” when COVID-19 was deemed a pandemic over a year ago. It was a unique danger for our time—not only was it invisible, but it posed a danger of dying. Flight can not only fit the social distance recommendations, butinternal
FIRST NEW TREATMENT APPROVED FOR ALZHEIMER DISEASE IN 1 day ago · This one-of-a-kind Alzheimer disease treatment targets the amyloid beta plaques in the brain, potentially slowing cognitive decline. Today, the US Food and Drug Administration (FDA) approved Biogen’s anti-amyloid, disease-modifying agent aducanumab for the treatment of Alzheimer disease PHARMACOLOGICAL AND NONPHARMACOLOGICAL APPROACHES TO DELIRIUM 1 day ago · John J. Miller, MD, talks about treatment options fordelirium
NEW HOPE FOR DEPRESSION ON THE HORIZON The US Food and Drug Administration has reviewed and accepted the New Drug Application (NDA) for LY03005, a serotonin-norepinephrine-dopamine triple reuptake inhibitor (SNDRI). Developed under Luye Pharma's New Chemical and Therapeutic Entities Research and Development platform, the company has obtained patents covering the chemical compound PSYCHIATRIC TIMESCMESPOTLIGHTCOMMENTARYCULTURAL CORNERPSYCHIATRICPRACTICESERIES
Next Steps. May 27, 2021. Climate change is a devastating existential threat that can exaggerate preexisting inequities and health/mental health problems. As mental health professionals committed to understanding deep emotional wounds and addressing complexities of relationships, psychiatrists have the tools to assist in bridging thecurrent gaps.
CONFRONTING THE METHAMPHETAMINE EPIDEMIC Methamphetamine use has been underrecognized compared with the opioid use epidemic, but it is a major health care concern, due to rapidly increasing usage of this drug and its highly addictive pharmacologic properties. Methamphetamine use poses many psychological and physiological challenges to users. PSYCHIATRIC SYMPTOMS ASSOCIATED WITH PARKINSON DISEASE5 STAGES OFPARKINSON S DISEASE
Parkinson disease (PD) is the second most common neurodegenerative illness in the United States, affecting more than 1 million persons. Disease onset is usually after age 50. In persons older than 70 years, the prevalence is 1.5% to 2.5%.1 While the primary pathology involves degeneration of dopaminergic neurons in the substantia nigra, circuits important in emotion and cognition-such as the STRATEGIES FOR TREATMENT-RESISTANT OCD Strategies for Treatment-Resistant OCD. October 16, 2014. Stefano Pallanti, MD, PhD. Stefano Pallanti, MD, PhD. Psychiatric Times, Vol 31 No 10, Volume 31, Issue 10. The clinician's role is to “translate” symptoms of OCD and understand the dysfunctional circuits at play to decide on the most appropriate treatment for eachpatient. Figure.
PANDEMIC DENIERS: WHAT’S WITH THEM? Pandemic Deniers: What’s With Them? September 8, 2020. Lawrence H. Climo, MD. Lawrence H. Climo, MD. Some individuals refuse to wear masks or practice social distancing. Why? And what might change their minds? Pandemics occur worldwide. I don't think it is a reach to assume that each time they appear they evoke fear, the desire to stay NEW HOPE FOR DEPRESSION ON THE HORIZON The US Food and Drug Administration has reviewed and accepted the New Drug Application (NDA) for LY03005, a serotonin-norepinephrine-dopamine triple reuptake inhibitor (SNDRI). Developed under Luye Pharma's New Chemical and Therapeutic Entities Research and Development platform, the company has obtained patents covering the chemical compound HOW TO SWITCH STIMULANTS: A DOSING GUIDE FOR ADHD To convert to a new duration with the same formulation, multiply the old dose by the ratio of (new duration) / (old duration). This will increase the dose if the new duration is longer, and lower the dose if the new duration is shorter. The adjustment ensures that the new medication will deliver the same milligrams per hour, but it is only a HOW TO WORK THROUGH EROTIC TRANSFERENCE The therapeutic usefulness of the erotic transference is twofold: the wealth of psychological material it yields in understanding both erotic and power issues and the strength of the emotional charge that initially sustains the patient through some hard work. However, to the degree that it persists, it becomes a limitation in the analysis. HOW TO MINIMIZE LAMOTRIGINE’S ADVERSE EFFECTS BRIEF COMMUNICATION. Lamotrigine’s favorable tolerability is a welcome advance for patients with bipolar disorder, particularly in the areas that matter most to patients: weight gain, fatigue, sex, and cognition. 1 Unlike other mood stabilizers, lamotrigine lacks long-term medical risks. Rather, the danger it poses is at the start of treatment, when its mood-lifting effects can easily be LOW-DOSE LITHIUM: A DIFFERENT, IMPORTANT TOOL Low-dose lithium is a different drug compared with full-dose lithium (eg, blood level of 0.8 mEq/L and higher). It has a far more benign side-effect and risk profile. And it has different potential targets: not so much the prevention of the next manic episode but rather adjunctive antidepressant and anti-suicide effects. PSYCHIATRIC TIMESCMESPOTLIGHTCOMMENTARYCULTURAL CORNERPSYCHIATRICPRACTICESERIES
Next Steps. May 27, 2021. Climate change is a devastating existential threat that can exaggerate preexisting inequities and health/mental health problems. As mental health professionals committed to understanding deep emotional wounds and addressing complexities of relationships, psychiatrists have the tools to assist in bridging thecurrent gaps.
CONFRONTING THE METHAMPHETAMINE EPIDEMIC Methamphetamine use has been underrecognized compared with the opioid use epidemic, but it is a major health care concern, due to rapidly increasing usage of this drug and its highly addictive pharmacologic properties. Methamphetamine use poses many psychological and physiological challenges to users. PSYCHIATRIC SYMPTOMS ASSOCIATED WITH PARKINSON DISEASE5 STAGES OFPARKINSON S DISEASE
Parkinson disease (PD) is the second most common neurodegenerative illness in the United States, affecting more than 1 million persons. Disease onset is usually after age 50. In persons older than 70 years, the prevalence is 1.5% to 2.5%.1 While the primary pathology involves degeneration of dopaminergic neurons in the substantia nigra, circuits important in emotion and cognition-such as the STRATEGIES FOR TREATMENT-RESISTANT OCD Strategies for Treatment-Resistant OCD. October 16, 2014. Stefano Pallanti, MD, PhD. Stefano Pallanti, MD, PhD. Psychiatric Times, Vol 31 No 10, Volume 31, Issue 10. The clinician's role is to “translate” symptoms of OCD and understand the dysfunctional circuits at play to decide on the most appropriate treatment for eachpatient. Figure.
PANDEMIC DENIERS: WHAT’S WITH THEM? Pandemic Deniers: What’s With Them? September 8, 2020. Lawrence H. Climo, MD. Lawrence H. Climo, MD. Some individuals refuse to wear masks or practice social distancing. Why? And what might change their minds? Pandemics occur worldwide. I don't think it is a reach to assume that each time they appear they evoke fear, the desire to stay NEW HOPE FOR DEPRESSION ON THE HORIZON The US Food and Drug Administration has reviewed and accepted the New Drug Application (NDA) for LY03005, a serotonin-norepinephrine-dopamine triple reuptake inhibitor (SNDRI). Developed under Luye Pharma's New Chemical and Therapeutic Entities Research and Development platform, the company has obtained patents covering the chemical compound HOW TO SWITCH STIMULANTS: A DOSING GUIDE FOR ADHD To convert to a new duration with the same formulation, multiply the old dose by the ratio of (new duration) / (old duration). This will increase the dose if the new duration is longer, and lower the dose if the new duration is shorter. The adjustment ensures that the new medication will deliver the same milligrams per hour, but it is only a HOW TO WORK THROUGH EROTIC TRANSFERENCE The therapeutic usefulness of the erotic transference is twofold: the wealth of psychological material it yields in understanding both erotic and power issues and the strength of the emotional charge that initially sustains the patient through some hard work. However, to the degree that it persists, it becomes a limitation in the analysis. HOW TO MINIMIZE LAMOTRIGINE’S ADVERSE EFFECTS BRIEF COMMUNICATION. Lamotrigine’s favorable tolerability is a welcome advance for patients with bipolar disorder, particularly in the areas that matter most to patients: weight gain, fatigue, sex, and cognition. 1 Unlike other mood stabilizers, lamotrigine lacks long-term medical risks. Rather, the danger it poses is at the start of treatment, when its mood-lifting effects can easily be LOW-DOSE LITHIUM: A DIFFERENT, IMPORTANT TOOL Low-dose lithium is a different drug compared with full-dose lithium (eg, blood level of 0.8 mEq/L and higher). It has a far more benign side-effect and risk profile. And it has different potential targets: not so much the prevention of the next manic episode but rather adjunctive antidepressant and anti-suicide effects. FIRST NEW TREATMENT APPROVED FOR ALZHEIMER DISEASE IN 1 day ago · This one-of-a-kind Alzheimer disease treatment targets the amyloid beta plaques in the brain, potentially slowing cognitive decline. Today, the US Food and Drug Administration (FDA) approved Biogen’s anti-amyloid, disease-modifying agent aducanumab for the treatment of Alzheimer disease FINDING THE DIFFICULT TRUTH 21 hours ago · A clinical approach to detecting false allegations of abuse in child custody cases. False allegations of abuse in child custody cases are an all-too-common phenomenon. Typically, one parent accuses the other parent of physical and/or sexual abuse of their child to gain leverage in their court THE PANDEMIC PROJECT: OUR READERS DESCRIBE THE YEAR OF It seems all of us started with some degree of built-in evolutionary reaction to perceived danger, “fight or flight,” when COVID-19 was deemed a pandemic over a year ago. It was a unique danger for our time—not only was it invisible, but it posed a danger of dying. Flight can not only fit the social distance recommendations, butinternal
PHARMACOLOGICAL AND NONPHARMACOLOGICAL APPROACHES TO DELIRIUM 22 hours ago · John J. Miller, MD, talks about treatment options fordelirium
FDA APPROVES A NEW ATYPICAL ANTIPSYCHOTIC WITH LESS This combination treatment of olanzapine and samidorphan caused significantly less weight gain in patients with schizophrenia and bipolar I disorder. The US Food and Drug Administration announced their approval of Alkermes’ LYBALVI, a combination of NEW HOPE FOR DEPRESSION ON THE HORIZON The US Food and Drug Administration has reviewed and accepted the New Drug Application (NDA) for LY03005, a serotonin-norepinephrine-dopamine triple reuptake inhibitor (SNDRI). Developed under Luye Pharma's New Chemical and Therapeutic Entities Research and Development platform, the company has obtained patents covering the chemical compound WHAT ARE THE NEUROSCIENTIFIC SECRETS TO SUCCESSFUL Key neural mechanisms are responsible for emotion, memory consolidation, and lasting personal change. Psychodynamic psychotherapy has receded into the background in many residency programs. But according to Richard D. Lane, MD, PhD, psychotherapy is not only foundational to the history of psychiatry OH, CANADA! YOUR NEW LAW WILL PROVIDE, NOT PREVENT These laws are being passed around the world, and they could profoundly change the practice of psychiatry. In concerned response to those developments, the American Psychiatric Association issued a position statement in 2016: “A psychiatrist should not prescribe or administer any intervention to a EULOGY FOR WALL STREET Memorial Day emboldens us to remember the men and women who sacrificed their lives for our freedom. We thank them for their service. It also day also represents the 100th anniversary of the Tulsa Massacre. I would like to honor the generations of YOU CAN'T BEAT THE SCREENS Dr Marco is a board-certified cognitive and behavioral pediatric neurologist, neuroscience researcher, and author. She specializes in the evaluation and treatment of children with sensory processing disorder, autism, and other neurodevelopmental conditions at Cortica in San Rafael, California. KidsSearch
Spotlight Case-Based Psych Perspectives-SchizophreniaADHD
ADHD: Strategies for Developing a Further DialogueBipolar
Disorder Major Depressive DisorderTardive Dyskinesia
Treating Schizophrenia CommentaryCouch In Crisis Early Career Psychiatry History of PsychiatryResidents Corner
Cultural CornerFilm and Book ReviewsPoetry
Writers Contest
Psychiatric PracticeBurnout CareersCoding
Guidelines
Risk Management
Telepsychiatry
SeriesClimate Change Critical Conversations in Psychiatry Portraits Tales from the New Asylum TopicsAll Topics Addiction & Substance Use Anxiety & Stress Disorders Bipolar Disorder Case DiscussionsDepression Forensic
Psychiatry Neuropsychiatry Personality DisordersPsychosomatics
Schizophrenia/Psychosis Sex & Sexuality SleepDisorders Suicide
MediaPsychView Case-Based Psych PerspectivesMedical World News
PsychPearls Podcast
Slideshows Videos
Viewpoints
PublicationsPsychiatric Times All Publications Partner PerspectivesJob Board
CME/CE
ResourcesClinical Scales Conference Coverage Conference Listing Interactive Tools Q&A Quizzes Special ReportsSponsored Tipsheets
Toolkits
SubscribeeNewsletterSubscription
Search
* Contact Us
* Editorial
* Terms and Conditions* Privacy Policy
* Do Not Sell My Personal Information*
*
2021 MJH Life Sciences and Psychiatric Times. All rights reserved.SpotlightSee All >
* Case-Based Psych Perspectives-Schizophrenia* ADHD
* ADHD: Strategies for Developing a Further Dialogue* Bipolar Disorder
* Major Depressive Disorder * Tardive Dyskinesia * Treating SchizophreniaCommentarySee All >
* Couch In Crisis
* Early Career Psychiatry * History of Psychiatry* Residents Corner
Cultural CornerSee All > * Film and Book Reviews* Poetry
* Writers Contest
Psychiatric PracticeSee All >* Burnout
* Careers
* Coding
* Guidelines
* Risk Management
* Telepsychiatry
SeriesSee All >
* Climate Change
* Critical Conversations in Psychiatry* Portraits
* Tales from the New Asylum* Contact Us
* Editorial
* Terms and Conditions* Privacy Policy
* Do Not Sell My Personal Information*
*
2021 MJH Life Sciences™ and Psychiatric Times. All rightsreserved.
DAY 29
June 4th 2021
"...now i forget what day it is and still feel i’m running out oftime..."
YOU CAN'T BEAT THE SCREENSJune 3rd 2021
Kids will find the screens. Health care providers should join them in order to supply the most helpful digital treatments. WHAT ARE THE NEUROSCIENTIFIC SECRETS TO SUCCESSFUL PSYCHOTHERAPY?June 3rd 2021
Key neural mechanisms are responsible for emotion, memory consolidation, and lasting personal change. GLOBAL PSYCHIATRY’S CRISIS OF VALUES: DAINIUS PŪRAS, MDJune 3rd 2021
In this installment of Conversations in Critical Psychiatry, a former United Nations Special Rapporteur discusses the need for a change in the status quo of mental health care. PSYCHIATRY COMIC: LOST PRIDEJune 3rd 2021
What's a man or beast to do? ARE WE A TRAUMATIZED NATION?June 02, 2021
ByH. Steven Moffic, MD What side of the rainbow are we on? OH, CANADA! YOUR NEW LAW WILL PROVIDE, NOT PREVENT, SUICIDE FOR SOME PSYCHIATRIC PATIENTSJune 01, 2021
Will a new Canadian law overturn long-held ethical norms inpsychiatry?
EULOGY FOR WALL STREETJune 01, 2021
Sometimes a few simple words help us remember important events. FDA APPROVES A NEW ATYPICAL ANTIPSYCHOTIC WITH LESS ADVERSE EFFECTSJune 01, 2021
This combination treatment of olanzapine and samidorphan caused significantly less weight gain in patients with schizophrenia andbipolar I disorder.
LESSONS FROM NOVEL HARM REDUCTION METHODSJune 01, 2021
How can understanding the opioid crisis in Canada inform strategies inthe United States?
WAXING AND WANING: PREVENTING DELIRIUMJune 01, 2021
What factors should be considered to help prevent delirium? DREAMING OF NEW TREATMENTSMay 30, 2021
Sleep problems are understudied, underdiagnosed, and undertreated. A NEW TARGET FOR INTERVENTION IN ALZHEIMER DISEASE?May 29, 2021
Gene expressions in microglia cells may explain why some of them are ineffective and allow dementia to progress. LOOKING TO THE FUTURE OF MDMA-ASSISTED PSYCHOTHERAPYMay 28, 2021
New research find altered states of consciousness may allow veterans and other patients with PTSD to face unspeakable experiences and findpeace.
CELEBRATING VETERANSMay 28, 2021
Veterans deserve our attention.Next >>
x
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0